Bartos Jason A, Voicu Sebastian, Matsuura Timothy R, Tsangaris Adamantios, Sideris Georgios, Oestreich Brett A, George Stephen A, Olson Matthew, Shekar Kadambari Chandra, Rees Jennifer N, Carlson Kathleen, Sebastian Pierre, McKnite Scott, Raveendran Ganesh, Aufderheide Tom P, Yannopoulos Demetris
Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN.
Medical and Toxicological Intensive Care Unit, Université Paris Diderot, Sorbonne Paris Cité, APHP, Lariboisière Hospital, 2 rue Ambroise Paré, 75475 Paris, France.
JACC Basic Transl Sci. 2017 Jun;2(3):244-253. doi: 10.1016/j.jacbts.2017.02.003. Epub 2017 Jun 21.
xtracorporeal membrane oxygenation (ECMO) is used in cardiopulmonary resuscitation (CPR) of refractory cardiac arrest. We used a 2×2 study design to compare ECMO versus CPR and epinephrine versus placebo in a porcine model of ischemic refractory ventricular fibrillation (VF). Pigs underwent 5 minutes of untreated VF, 10 minutes of CPR, and were randomized to receive epinephrine versus placebo for another 35 minutes. Animals were further randomized to LAD reperfusion at minute 45 with ongoing CPR versus veno-arterial ECMO cannulation at minute 45 of CPR and subsequent LAD reperfusion. Four-hour survival was improved with ECMO while epinephrine showed no effect.
体外膜肺氧合(ECMO)用于难治性心脏骤停的心肺复苏(CPR)。我们采用2×2研究设计,在猪缺血性难治性室颤(VF)模型中比较ECMO与CPR以及肾上腺素与安慰剂。猪经历5分钟未经处理的VF、10分钟的CPR,然后随机接受肾上腺素或安慰剂治疗35分钟。动物进一步随机分为在45分钟时进行左前降支(LAD)再灌注并持续CPR组,以及在CPR 45分钟时进行静脉-动脉ECMO插管并随后进行LAD再灌注组。ECMO可提高4小时生存率,而肾上腺素无效果。